Incidence of damage to the crystalline lens during intravitreal injections

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 5, 2010, Pages 491-495

  Meyer, Carsten H ^a   Rodrigues, Eduardo B ^b   Michels, Stephan ^c   Mennel, Stefan ^d   Schmidt, Jörg C ^d,e   Helb, Hans Martin ^a   Hager, Annette ^a   Martinazzo, Mauricio ^b   Farah, Michel E ^b  

^a UNIVERSITY OF BONN   (Germany)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c TRIEMLI HOSPITAL   (Switzerland)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e House of Thousand Windows   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERMETROPIA; INTRAVITREAL DRUG ADMINISTRATION; LENS DISEASE; MALE; PARACENTESIS; PHAKIC INTRAOCULAR LENS; RETROSPECTIVE STUDY; TRAUMATIC LENS INJURY;

AGED; AGED, 80 AND OVER; CATARACT; FEMALE; HUMANS; HYPEROPIA; IATROGENIC DISEASE; INCIDENCE; INTERVENTION STUDIES; INTRAVITREAL INJECTIONS; LENS IMPLANTATION, INTRAOCULAR; LENS, CRYSTALLINE; MALE; MULTICENTER STUDIES AS TOPIC; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITREOUS BODY;

EID: 77957941977     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0045     Document Type: Article

References (24)

1. Aiello, L.P., Brucker, A.J., Chan, S., Cunningham, Jr., E.T., D'Amico, D.J., Flynn, Jr., H.W., Grillone, L.R., Hutcherson, S., Liebmann, J.M., O'Brien, T.P., Scott, I.U., Spaide, R.F., Ta, C., and Trese, M.T. Evolving guidelines for intravitreous injections. Retina 4:S3-S19, 2004.
2. Jager, R.D., Aiello, L.P., Patel, S.C., and Cunningham, Jr., E.T. Risks of intravitreous injection: a comprehensive review. Retina 24:676-698, 2004.
3. Scott, I.U., and Flynn,H.W. Reducing the risk of endophthalmitis following intravitreal injections. Retina 27:10-12, 2007.
4. Chan, C.K., Abraham, P., Meyer, C.H., Kokame, G.T., Kaiser, P.K., Rauser, M.E., Gross, J.G., Nuthi, A.S., Lin, S.G., and Daher, D.S. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal segment epithelial tears associated with intravitreal bevacizumab injections. Retina 30:203-211, 2010.
5. Dayani, P.N., Siddiqi, O.K., and Holekamp, N.M. Safety of intravitreal injections in patients receiving warfarin anticoagulation. Am. J. Ophthalmol. 14:451-453, 2007.
6. Gupta, R., Negi, A., and Vernon, S.A. Severe subconjunctival hemorrhage following intravitreal triamcinolone for refractory diabetic oedema. Eye 19:590-591, 2005. (Pubitemid 40711718)
7. Meyer, C.H., Ziemssen, F., and Heimann, H. Intravitreal injection. Monitoring to avoid postoperative complications. Ophthalmologe 105:143-157, 2008.
8. Pilli, S., Kotsolis, A., Spaide, R.F., Slakter, J., Freund, K.B., Sorenson, J., Klancnik, J., and Cooney, M. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am. J. Ophthalmol. 145:879-882, 2008.
9. Wu, L., Martýńez-Castellanos, M.A., Quiroz-Mercado, H., Arevalo, J.F., Berrocal, M.H., Farah, M.E., Maia, M., Roca, J.A., and Rodriguez, F.J.; Pan American Collaborative Retina Group (PACORES). Twelve-month safety of intravitreal injections of bevacizumab (Avastin(R)): results of the Pan- American Collaborative Retina Study Group (PACORES). Graefes Arch. Clin. Exp. Ophthalmol. 246:81-87, 2008.
10. Fung, A.E., Rosenfeld, P.J., and Reichel, E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br. J. Ophthalmol. 90:1344-1349, 2006.
11. Gragoudas, E.S., Adamis, A.P., Cunningham, Jr., E.T., Feinsod, M., and Guyer, D.R.; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351:2805-2816, 2004.
12. Rodrigues, E.B., Meyer C.H., Grumann, Jr., A., Shiroma, H., Aguni, J.S., and Farah, M.E. Tunneled scleral incision to prevent vitreal reflux after intravitreal injection. Am. J. Ophthalmol. 143:1035-1037, 2007.
13. Ohm, J. Ü ber die Behandlung der Netzhautablösung durch operative Entleerung der subretinalen Flü ssigkeit und Einspritzen vom Luft in den Glaskö rper. Graefes Arch. Klin. Ophthalmol. 79:442-450, 1911.
14. Smiddy, W.E., Michels, R.G., and Green, W.R. Lens and peripheral retinal relationships during vitrectomy. Retina 11:199-203, 1991.
15. Chen, S.D., Mohammed, Q., Bowling, B., and Patel, C.K. Vitreous wick syndrome-a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana. Am. J. Ophthalmol. 137:1159-1160, 2004.
16. Rodrigues, E.B., Meyer, C.H., Schmidt, J.C., Hoerle, S., and Kroll, P. Unsealed sclerotomy after intravitreal injection with a 30-gauge needle. Retina 24:810-812, 2004.
17. Pulido, J.S., Pulido, C.M., Bakri, S.J. McCannel, C.A., and Cameron, J.D. The use of 31-gauge needles and syringes for intraocular injections. Eye 21:829-830, 2007.
18. Hochman, M.N., and Friedman, M.J. An in vitro study of needle force penetration comparing a standard linear insertion to the new bidirectional rotation insertion technique. Quintessence Int. 32:789-796, 2001.
19. Kozak, I., Dean, A., Clark, T.M., Falkenstein, I., and Freeman, W.R. Prefilled syringe needles versus standard removable needles for intravitreous injection. Retina 26:679-683, 2006.
20. Vedrine, L., Prais, W., Laurent, P.E., Raynal-Olive, C., and Fantino, M. Improving needle-point sharpness in prefillable syringes. Med. Device Technol. 14:32-35, 2003.
21. Brown, D.M., Kaiser, P.K., Heier, J.S., Sy, J.P., and Ianchulev, T.; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355:1432-1444, 2006.
22. Rosenfeld, P.J., Brown, D.M., Heier, J.S., Boyer, D.S., Kaiser, P.K., and Chung, C.Y., Kim, R.Y.; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355:1419-1431, 2006.
23. Meyer, C.H., Scholl, H.P., Eter, N., Helb, H.M., and Holz, F.G. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol. 86:490-494, 2008.
24. Sacu, S., Stifter, E., Vécsei-Marlovits, P.V., Michels, S., Michels, S., Schü tze, C., Prünte, C., and Schmidt-Erfurth, U. Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye 23:1404-1410, 2009.